Sale

Connected Drug Delivery Devices Market

Global Connected Drug Delivery Devices Market Size, Growth: By Product Type: Connected Sensors, Connected Inhaler Sensors, Connected Injection Sensors, Integrated Connected Devices, Integrated Inhalation Devices, Integrated Injection Devices Others; By Technology; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Connected Drug Delivery Devices Market Outlook

The global connected drug delivery devices market size attained a value of USD 541.12 million in 2023 as the rapid surge in Bluetooth segment is expected to fuel the market growth. The market is anticipated to grow at a CAGR of 31.5% during the forecast period of 2024-2032 to attain a value of USD 6,362.49 million by 2032.

 

connected drug delivery devices market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America Holds a Significant Share in the Growing Market of Connected Drug Delivery Devices

North America holds a significant share in the connected drug delivery devices market on account of the speedy adoption of the latest technologies and high per capita healthcare expenditure. The rising awareness regarding the harmful effects that can result from non-compliance with drug therapy is likely to boost the market growth across the globe in the coming years.

 

The rapid acceptance of wireless & wi-fi-enabled remote drug delivery systems coupled with the surging consumption of integrated devices is expected to bolster the market growth in the region. Moreover, factors like the high presence of major market players like Phillips-Medisize Corporation and advanced applications of medical devices are expected to propel the market growth further in North America.

 

Market Segmentation

Specialised smart electronics, connected drug delivery devices support wireless connectivity and are used to dispense therapy that is patient administered. These devices are fully equipped with a wide range of sensors and other electronics. The various components work together to support multiple features, helping patents track their medication doses and overall adherence, while providing tools for further patient education.

 

connected drug delivery devices market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By type, the connected drug delivery devices market is divided into:

  • Connected Sensors
  • Connectable Injection Sensors
  • Connected Inhaler Sensors
  • Integrated Connected Devices
  • Connected Inhalation Devices
  • Connected Injection Devices
  • Others

 

Based on technology, the market is categorised into:

  • Near Field Communication (NFC)
  • Bluetooth
  • Others

 

On the basis of end use, the market is segmented into:

  • Hospitals
  • Homecare

 

The EMR report looks into the regional markets like Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa.

 

connected drug delivery devices market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rapid Rise of Bluetooth Segment to Propel the Market Growth of Connected Drug Delivery Devices

On the basis of technology, the Bluetooth segment is expected to fuel the market growth on account of its high usage in drug delivery devices coupled with technology advancements. The several benefits of Bluetooth usage like extended battery life, low costs, and easy availability are driving the segment growth in the connected drug delivery devices market.

 

Moreover, the rising popularity of electronic drug delivery devices, technological advancements, and the surging awareness of self-administered therapy are further anticipated to spur the market growth over the upcoming years. The increasing prevalence of diabetes along with the rising preference for homecare medication because of the surging product acceptance in homecare settings are expected to fuel the market growth.

 

Key Players in the Global Market for Connected Drug Delivery Devices

The report presents a detailed analysis of the following key players in the global connected drug delivery devices market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

 

  • Adherium Limited
  • Propeller Health
  • Teva Pharmaceutical Industries Ltd.
  • Phillips-Medisize (Molex, LLC)
  • Elcam Drug Delivery Devices
  • Others

 

The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Technology
  • End User
  • Region
Breakup by Product Type
  • Connected Sensors
  • Connected Inhaler Sensors
  • Connected Injection Sensors
  • Integrated Connected Devices
  • Integrated Inhalation Devices
  • Integrated Injection Devices
  • Others
Breakup by Technology
  • Near Field Communication (NFC)
  • Bluetooth
  • Other
Breakup by End User
  • Healthcare Providers
  • Homecare
  • Hospitals
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • BD
  • F. Hoffmann-La Roche Ltd.
  • Propeller Health
  • BioCorp
  • Antares Pharma
  • Novartis AG
  • 3M
  • Sulzer Ltd.
  • Gerresheimer AG
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • GlaxoSmithKline plc.
  • Novosanis
  • MEDMIX SYSTEMS AG
  • Merck & Co., Inc.
  • Pfizer Inc.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Connected Drug Delivery Devices Market Overview 

    3.1    Global Connected Drug Delivery Devices Market Historical Value (2017-2023)
    3.2    Global Connected Drug Delivery Devices Market Forecast Value (2024-2032)
4    Global Connected Drug Delivery Devices Market  Landscape
    4.1    Global Connected Drug Delivery Devices Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Connected Drug Delivery Devices Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by End User
5    Global Connected Drug Delivery Devices Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Connected Drug Delivery Devices Market Segmentation 
    6.1    Global Connected Drug Delivery Devices Market by Product Type
        6.1.1    Market Overview
        6.1.2    Connected Sensors
        6.1.3    Connected Inhaler Sensors
        6.1.4    Connected Injection Sensors
        6.1.5    Integrated Connected Devices
        6.1.6    Integrated Inhalation Devices
        6.1.7    Integrated Injection Devices
        6.1.8    Others
    6.2    Global Connected Drug Delivery Devices Market by Technology
        6.2.1    Market Overview
        6.2.2    Near Field Communication (NFC)
        6.2.3    Bluetooth
        6.2.4    Other
    6.3    Global Connected Drug Delivery Devices Market by End User
        6.3.1    Market Overview
        6.3.2    Healthcare Providers
        6.3.3    Homecare
        6.3.4    Hospitals 
        6.3.5    Others
    6.4    Global Connected Drug Delivery Devices Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Connected Drug Delivery Devices Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Connected Drug Delivery Devices Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Connected Drug Delivery Devices Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Connected Drug Delivery Devices Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Connected Drug Delivery Devices Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    BD
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    F. Hoffmann-La Roche Ltd.
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Propeller Health
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    BioCorp
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Antares Pharma
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Novartis AG
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    3M
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Sulzer Ltd.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Gerresheimer AG
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Sanofi
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Johnson & Johnson Services, Inc.
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Bayer AG
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    GlaxoSmithKline plc.
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
    17.14    Novosanis
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
    17.15    MEDMIX SYSTEMS AG
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisitions
        17.15.5    Certifications
    17.16    Merck & Co., Inc.
        17.16.1    Financial Analysis
        17.16.2    Product Portfolio
        17.16.3    Demographic Reach and Achievements
        17.16.4    Mergers and Acquisitions
        17.16.5    Certifications
    17.17    Pfizer Inc.
        17.17.1    Financial Analysis
        17.17.2    Product Portfolio
        17.17.3    Demographic Reach and Achievements
        17.17.4    Mergers and Acquisitions
        17.17.5    Certifications
18    Global Connected Drug Delivery Devices Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global market for connected drug delivery devices reached a value of USD 541.12 million.

The market is anticipated to grow at a CAGR of 31.5% during the forecast period of 2024-2032 to reach a value of USD 6,362.49 million by 2032.

The major market drivers are the high per capita healthcare expenditure and increasing awareness about the harmful effects of non-compliance with drug therapy.

The key market trends include emerging economies along with surging cases of chronic diseases and the increasing advent of technology and wi-fi-enabled devices.

The major regions in the market as identified by the EMR report are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The various types of devices in the market include connected sensors, and integrated connected devices, among others.

The various technologies available in the market include near field communication (NFC), and Bluetooth, among others.

The primary end uses include hospitals and homecare.

The major players in the market are Adherium Limited, Propeller Health, Teva Pharmaceutical Industries Ltd., Phillips-Medisize (Molex, LLC), and Elcam Drug Delivery Devices, among others.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER